Amrize Ltd (AMRZ) – What Are Brokerages Saying About This Stock?

Amrize Ltd (NYSE:AMRZ – Get Free Report) has earned an average recommendation of “Hold” from the nineteen analysts that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and eight have assigned a buy recommendation to the company. The average 1-year price target among analysts that have covered the stock in the last year is $47.65.

A number of equities analysts have recently weighed in on the stock. Longbow Research initiated coverage on shares of Amrize in a research report on Monday, October 12th. They set a “buy” rating on the stock. Wall Street Zen downgraded shares of Amrize from a “hold” rating to a “sell” rating in a report on Saturday, November 7th. Stephens cut their price target on shares of Amrize from $65.00 to $54.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 12th. Wells Fargo & Company reduced their price target on shares of Amrize from $40.00 to $39.00 and set an “equal weight” rating for the company in a report on Friday, October 30th. Finally, Sanford C. Bernstein reiterated an “outperform” rating and issued a $60.00 price target on shares of Amrize in a report on Monday, September 21st.

View Our Latest Analysis on AMRZ

Amrize Stock Down 0.1%

Amrize stock opened at $40.85 on Wednesday. The company’s 50 day simple moving average is $39.33 and its 200 day simple moving average is $49.98. Amrize has a fifty-two week low of $35.78 and a fifty-two week high of $65.94. The firm has a market capitalization of $22.59 billion, a price-to-earnings ratio of 18.49, a PEG ratio of 1.60 and a beta of 0.03. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.07 and a quick ratio of 0.67.

Amrize (NYSE:AMRZ – Get Free Report) last issued its quarterly earnings data on Wednesday, October 28th. The company reported $1.05 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $1.05. Amrize had a net margin of 9.93% and a return on equity of 10.02%. The firm had revenue of $3.77 billion during the quarter. During the same quarter in the prior year, the firm posted $0.98 EPS. The firm’s revenue for the quarter was up 2.6% compared to the same quarter last year. As a group, sell-side analysts anticipate that Amrize will post 2.30 EPS for the current year.

Amrize Announces Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, November 18th. Investors of record on Tuesday, November 10th will be given a $0.11 dividend. The ex-dividend date of this dividend is Tuesday, November 10th. Amrize’s payout ratio is currently 4.98%.

Insider Buying and Selling at Amrize

In other news, Director Jacques Sanche bought 4,150 shares of the stock in a transaction on Wednesday, August 26th. The stock was purchased at an average price of $45.02 per share, for a total transaction of $186,833.00. Following the acquisition, the director owned 9,766 shares in the company, valued at approximately $439,665.32. This trade represents a 73.90% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Jan Jenisch bought 4,000 shares of the stock in a transaction on Wednesday, September 2nd. The shares were purchased at an average price of $42.50 per share, with a total value of $170,000.00. Following the acquisition, the chief executive officer owned 519,000 shares in the company, valued at approximately $22,057,500. This represents a 0.78% increase in their position. The SEC filing for this purchase provides additional information. Insiders purchased a total of 34,155 shares of company stock worth $1,461,276 over the last ninety days. 0.54% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently modified their holdings of AMRZ. Amundi lifted its position in Amrize by 30.9% during the 1st quarter. Amundi now owns 1,654,739 shares of the company’s stock worth $92,698,000 after buying an additional 390,750 shares in the last quarter. DJE Kapital AG boosted its stake in shares of Amrize by 45.9% during the 1st quarter. DJE Kapital AG now owns 1,113,036 shares of the company’s stock worth $60,194,000 after buying an additional 350,149 shares during the last quarter. Great Lakes Advisors LLC acquired a new position in shares of Amrize during the 2nd quarter worth about $16,975,000. Ancora Advisors LLC bought a new position in shares of Amrize in the 2nd quarter valued at about $15,112,000. Finally, Pictet Asset Management Holding SA grew its holdings in shares of Amrize by 4.3% in the 3rd quarter. Pictet Asset Management Holding SA now owns 6,126,150 shares of the company’s stock valued at $230,110,000 after acquiring an additional 253,512 shares in the last quarter.

Amrize Company Profile

(Get Free Report)

Amrize is a North American building materials and construction solutions company serving customers across the United States and Canada. Its operations span the construction materials and building envelope markets. The company supplies cement, aggregates, ready-mix concrete and asphalt, as well as roofing and other building-envelope products and services. These materials and solutions support residential, commercial and infrastructure projects. Amrize became an independent publicly traded company in 2025 through the spin-off of Holcim’s North American business.

Featured Stories

Analyst Recommendations for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.